{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:38:42Z","timestamp":1793227122614,"version":"4.5.0"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.micpath.2025.107940","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:13:01Z","timestamp":1753888381000},"page":"107940","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Microbiome modulation in dermatological disorders: Current insights and therapeutic prospects - A narrative review"],"prefix":"10.1016","volume":"208","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4487-5223","authenticated-orcid":false,"given":"Muhammad Liaquat","family":"Raza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Ibrahim","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areej","family":"Bhojani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubab","family":"Zehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rimsha","family":"Zehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.micpath.2025.107940_bib1","first-page":"475","article-title":"Skin microbiome: considerations for maintenance and modulation","volume":"31","author":"Lee","year":"2022","journal-title":"Exp. Dermatol."},{"issue":"7","key":"10.1016\/j.micpath.2025.107940_bib2","first-page":"803","article-title":"Skin microbiome and its relationship with skin diseases","volume":"61","author":"Carmona-Cruz","year":"2022","journal-title":"Int. J. Dermatol."},{"issue":"5931","key":"10.1016\/j.micpath.2025.107940_bib3","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1126\/science.1171700","article-title":"Topographical and temporal diversity of the human skin microbiome","volume":"324","author":"Grice","year":"2011","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.micpath.2025.107940_bib4","article-title":"Role of aryl hydrocarbon receptor in skin barrier function and disease","volume":"131","author":"Uberoi","year":"2021","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.micpath.2025.107940_bib5","first-page":"620","article-title":"Staphylococcus epidermidis promotes skin barrier function by secreting sphingomyelinase","volume":"7","author":"Zheng","year":"2022","journal-title":"Nat. Microbiol."},{"issue":"12","key":"10.1016\/j.micpath.2025.107940_bib6","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1111\/jdv.13965","article-title":"Microbiome in healthy skin, update for dermatologists","volume":"30","author":"Dr\u00e9no","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107940_bib7","first-page":"2","article-title":"The role of skin microbiome in atopic dermatitis: a systematic review","volume":"109","author":"Zhu","year":"2023","journal-title":"J. Dermatol. Sci."},{"issue":"2","key":"10.1016\/j.micpath.2025.107940_bib8","first-page":"75","article-title":"Skin microbiome and atopic dermatitis: pathogenesis and therapeutic perspectives","volume":"17","author":"\u00c7etinarslan","year":"2023","journal-title":"Turkish Journal of Dermatology"},{"issue":"2","key":"10.1016\/j.micpath.2025.107940_bib9","first-page":"287","article-title":"The role of the skin microbiome in atopic dermatitis: a systematic review","volume":"184","author":"Bjerre","year":"2021","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107940_bib10","first-page":"17","article-title":"Seborrheic dermatitis: pathophysiology and treatment update","volume":"14","author":"Jackson","year":"2024","journal-title":"Dermatol. Ther."},{"issue":"3","key":"10.1016\/j.micpath.2025.107940_bib11","first-page":"32","article-title":"Risk factors and pathogenesis of seborrheic dermatitis","volume":"17","author":"Woolhiser","year":"2024","journal-title":"Journal of Clinical and Aesthetic Dermatology"},{"key":"10.1016\/j.micpath.2025.107940_bib12","first-page":"1","article-title":"Malassezia and seborrheic dermatitis: current perspectives","volume":"17","author":"Tynes","year":"2024","journal-title":"Clin. Cosmet. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.micpath.2025.107940_bib13","first-page":"123","article-title":"Hidradenitis suppurativa: current concepts of pathogenesis and treatment","volume":"34","author":"Sabat","year":"2025","journal-title":"Exp. Dermatol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107940_bib14","first-page":"88","article-title":"Microbiome changes in hidradenitis suppurativa: pathophysiology and comorbidities","volume":"145","author":"McCarthy","year":"2025","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107940_bib15","article-title":"Cutibacterium acnes and acne vulgaris: insights into pathogenesis and treatment","volume":"11","author":"Xu","year":"2019","journal-title":"Derm. Endocrinol."},{"issue":"2","key":"10.1016\/j.micpath.2025.107940_bib16","first-page":"123","article-title":"Acne microbiome: update on pathophysiology and treatment","volume":"25","author":"Dessinioti","year":"2024","journal-title":"Am. J. Clin. Dermatol."},{"issue":"2","key":"10.1016\/j.micpath.2025.107940_bib17","first-page":"611","article-title":"Comparison of bacterial microbiota in psoriasis, eczema and healthy skin","volume":"132","author":"Fahl\u00e9n","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.micpath.2025.107940_bib18","article-title":"Psoriasis and the skin microbiome: emerging relationships","volume":"14","author":"Celoria","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2025.107940_bib19","article-title":"Role of Staphylococcus aureus in atopic dermatitis: from pathogenesis to targeted therapy","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.micpath.2025.107940_bib20","first-page":"723","article-title":"Staphylococcus aureus colonization and skin dysbiosis in atopic dermatitis: a systematic review","volume":"37","author":"Demessant-Flavigny","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"3","key":"10.1016\/j.micpath.2025.107940_bib21","first-page":"392","article-title":"Microbial imbalance and skin inflammation in atopic dermatitis","volume":"72","author":"Tamai","year":"2023","journal-title":"Allergol. Int."},{"issue":"4","key":"10.1016\/j.micpath.2025.107940_bib22","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.immuni.2015.03.014","article-title":"Dysbiosis and Staphylococcus aureus colonization drives inflammation in atopic dermatitis","volume":"42","author":"Kobayashi","year":"2015","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.micpath.2025.107940_bib23","first-page":"973","article-title":"Protective role of Staphylococcus epidermidis in skin microbiome","volume":"59","author":"Manne","year":"2020","journal-title":"Int. J. Dermatol."},{"issue":"2","key":"10.1016\/j.micpath.2025.107940_bib24","first-page":"85","article-title":"Protease activity of Staphylococcus epidermidis contributes to host defense","volume":"71","author":"Vandecandelaere","year":"2014","journal-title":"Pathogens and Disease"},{"issue":"3","key":"10.1016\/j.micpath.2025.107940_bib25","first-page":"243","article-title":"The protective effect of Staphylococcus epidermidis biofilm against skin pathogens","volume":"72","author":"Sugimoto","year":"2013","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.micpath.2025.107940_bib26","article-title":"Antimicrobial peptides and skin barrier: relevance in dermatological disorders","volume":"15","author":"Bucataru","year":"2024","journal-title":"Front. Microbiol."},{"issue":"5","key":"10.1016\/j.micpath.2025.107940_bib27","first-page":"543","article-title":"Antimicrobial peptides in cutaneous infections and inflammatory diseases","volume":"33","author":"Fontanot","year":"2024","journal-title":"Exp. Dermatol."},{"issue":"12","key":"10.1016\/j.micpath.2025.107940_bib28","first-page":"6754","article-title":"Human \u03b2-defensins and their role in skin immunity","volume":"23","author":"Li","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2025.107940_bib29","article-title":"Antimicrobial peptides in skin homeostasis and disease","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.micpath.2025.107940_bib30","first-page":"83","article-title":"Antimicrobial peptides: role in human health and disease","volume":"20","author":"Lazzaro","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.micpath.2025.107940_bib31","first-page":"1806","article-title":"The role of antimicrobial peptides in the skin immune defense against Streptococcus pyogenes","volume":"122","author":"Vega","year":"2012","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.micpath.2025.107940_bib32","first-page":"211","article-title":"Cutibacterium acnes biofilm and its role in acne pathogenesis","volume":"33","author":"d'Epenoux","year":"2024","journal-title":"Exp. Dermatol."},{"issue":"3","key":"10.1016\/j.micpath.2025.107940_bib33","first-page":"877","article-title":"Biofilm formation in acne: emerging role of skin microbiota","volume":"12","author":"Abbott","year":"2022","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.micpath.2025.107940_bib34","first-page":"8","article-title":"Biofilm formation by Cutibacterium acnes in human skin","volume":"52","author":"Kuehnast","year":"2018","journal-title":"Anaerobe"},{"issue":"1","key":"10.1016\/j.micpath.2025.107940_bib35","first-page":"155","article-title":"Role of fusobacterium species in hidradenitis suppurativa","volume":"14","author":"\u015awierczewska","year":"2025","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.micpath.2025.107940_bib36","first-page":"1403","article-title":"Anaerobic bacteria and hidradenitis suppurativa: a review","volume":"182","author":"Williams","year":"2020","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.1016\/j.micpath.2025.107940_bib37","first-page":"1149","article-title":"The microbiome of tunnels in hidradenitis suppurativa patients","volume":"29","author":"Ring","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107940_bib38","first-page":"45","article-title":"Competitive exclusion in burn wounds: corynebacterium striatum versus Pseudomonas aeruginosa","volume":"51","author":"\u0218andru","year":"2025","journal-title":"Burns"},{"key":"10.1016\/j.micpath.2025.107940_bib39","first-page":"505","article-title":"Iron sequestration by commensal bacteria in cutaneous infections","volume":"10","author":"Perraud","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"4","key":"10.1016\/j.micpath.2025.107940_bib40","first-page":"429","article-title":"Siderophores and competition for iron in bacterial communities","volume":"41","author":"Harrison","year":"2017","journal-title":"FEMS (Fed. Eur. Microbiol. Soc.) Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.micpath.2025.107940_bib41","first-page":"2341","article-title":"Lantibiotics from staphylococcus Epidermidis: role in pathogen antagonism","volume":"15","author":"Puls","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2025.107940_bib42","first-page":"774","article-title":"Lantibiotics from staphylococci: novel antimicrobial peptides","volume":"9","author":"Ebner","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2025.107940_bib43","first-page":"59","article-title":"Antimicrobial peptides from skin commensals","volume":"21","author":"G\u00f6tz","year":"2014","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.micpath.2025.107940_bib44","article-title":"Bacterial \u03b2-glucuronidase and skin infections: role in Candida albicans overgrowth","volume":"14","author":"Ma","year":"2024","journal-title":"Frontiers in Cellular Microbiology"},{"key":"10.1016\/j.micpath.2025.107940_bib45","article-title":"Dysbiosis and Candida albicans infections: mechanistic insights","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.micpath.2025.107940_bib46","first-page":"715","article-title":"Microbiome imbalance and susceptibility to Candida albicans","volume":"55","author":"Tan","year":"2017","journal-title":"Med. Mycol."},{"issue":"3","key":"10.1016\/j.micpath.2025.107940_bib47","first-page":"321","article-title":"The microbiome as a therapeutic target in infectious skin diseases","volume":"33","author":"Avelar","year":"2024","journal-title":"Exp. Dermatol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107940_bib48","first-page":"41","article-title":"Pattern recognition receptors and the skin microbiome: immune interactions","volume":"24","author":"Carroll","year":"2024","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.micpath.2025.107940_bib49","first-page":"329","article-title":"The regulation of innate and adaptive immune responses by PRRs","volume":"48","author":"Amarante-Mendes","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.micpath.2025.107940_bib50","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-immunol-032414-112240","article-title":"Innate immune pattern recognition: a cell biological perspective","volume":"33","author":"Brubaker","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.micpath.2025.107940_bib51","article-title":"Lipoteichoic acid from commensal bacteria activates TLR2 and promotes IL-17A production","volume":"15","author":"Zhu","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107940_bib52","first-page":"43","article-title":"Microbiome-immune crosstalk through pattern-recognition receptors","volume":"22","author":"Duan","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107940_bib53","first-page":"35","article-title":"TLR2-mediated IL-17 response to candida in human skin","volume":"97","author":"Saito","year":"2020","journal-title":"J. Dermatol. Sci."},{"issue":"6","key":"10.1016\/j.micpath.2025.107940_bib54","first-page":"1376","article-title":"Innate recognition of commensal bacteria through PRRs in skin immunity","volume":"44","author":"Kang","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.micpath.2025.107940_bib55","article-title":"Th17 dysregulation in psoriasis: microbiome-Mediated mechanisms","volume":"15","author":"Zhao","year":"2024","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.micpath.2025.107940_bib56","first-page":"1524","article-title":"Streptococcus pyogenes superantigens and psoriasis exacerbation","volume":"31","author":"Kim","year":"2022","journal-title":"Exp. Dermatol."},{"issue":"8","key":"10.1016\/j.micpath.2025.107940_bib57","article-title":"Dysbiosis in psoriasis: microbiota and tight junction defects","volume":"11","author":"Z\u00e1kostelsk\u00e1","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.micpath.2025.107940_bib58","first-page":"712","article-title":"Psoriatic arthritis: pathogenesis and role of microbiome","volume":"44","author":"Mease","year":"2015","journal-title":"Semin. Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.micpath.2025.107940_bib59","first-page":"512","article-title":"Regulatory T cells and indole metabolites in skin immune responses","volume":"144","author":"Boccardo","year":"2024","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.micpath.2025.107940_bib60","first-page":"245","article-title":"Malassezia metabolites and immune dysregulation","volume":"59","author":"Corzo-Leon","year":"2021","journal-title":"Med. Mycol."},{"key":"10.1016\/j.micpath.2025.107940_bib61","first-page":"2795","article-title":"Tregs in skin immunity: balancing tolerance and inflammation","volume":"9","author":"Johansson","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107940_bib62","first-page":"139","article-title":"Influence of Malassezia and microbial metabolites on neonatal T cell responses","volume":"136","author":"Gabrielsson","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.micpath.2025.107940_bib63","article-title":"Probiotic interventions in dermatology: mechanisms and clinical evidence","volume":"14","author":"Gao","year":"2023","journal-title":"Front. Microbiol."},{"issue":"5","key":"10.1016\/j.micpath.2025.107940_bib64","article-title":"Probiotics in dermatological health: current perspectives and future challenges","volume":"32","author":"Kim","year":"2019","journal-title":"Dermatol. Ther."},{"issue":"1","key":"10.1016\/j.micpath.2025.107940_bib65","first-page":"565","article-title":"Prebiotics: an emerging therapeutic strategy for gut and skin microbiota modulation","volume":"20","author":"Yadav","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.micpath.2025.107940_bib66","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3389\/fcimb.2019.00454","article-title":"How probiotics affect the microbiota","volume":"9","author":"Wie\u00ebrs","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"5","key":"10.1016\/j.micpath.2025.107940_bib67","first-page":"1638","article-title":"Probiotics modulate the gut-skin axis to improve atopic dermatitis: a systematic review","volume":"13","author":"Fang","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.micpath.2025.107940_bib68","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jamadermatol.2017.3647","article-title":"Effect of oral administration of a mixture of probiotic strains on SCORAD index and use of topical steroids in young patients with moderate atopic dermatitis: a randomized clinical trial","volume":"154","author":"Navarro-L\u00f3pez","year":"2018","journal-title":"JAMA Dermatol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107940_bib69","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/exd.14032","article-title":"The role of topical probiotics in skin conditions: a systematic review of animal and human studies and implications for future therapies","volume":"29","author":"Knackstedt","year":"2020","journal-title":"Exp. Dermatol."},{"issue":"5","key":"10.1016\/j.micpath.2025.107940_bib70","first-page":"1118","article-title":"Probiotic supplementation as an adjuvant therapy in atopic dermatitis: a randomized controlled trial","volume":"41","author":"de Andrade","year":"2022","journal-title":"Clin. Nutr."},{"issue":"3","key":"10.1016\/j.micpath.2025.107940_bib71","first-page":"9219","article-title":"Probiotics as adjuvant therapy for atopic dermatitis: a randomized controlled trial in children","volume":"14","author":"Umborowati","year":"2022","journal-title":"Dermatol. Rep."},{"issue":"15","key":"10.1016\/j.micpath.2025.107940_bib72","first-page":"8345","article-title":"Prebiotics and skin barrier: evidence from clinical and experimental studies","volume":"23","author":"Petrov","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.micpath.2025.107940_bib73","first-page":"346","article-title":"Inulin and \u03b2-glucan supplementation ameliorates atopic dermatitis severity in mice through microbiome modulation","volume":"15","author":"Kang","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.micpath.2025.107940_bib74","article-title":"Gut-skin axis modulation in psoriasis: emerging therapeutic perspectives","volume":"15","author":"Min","year":"2024","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.micpath.2025.107940_bib75","first-page":"1174","article-title":"The role of prebiotics and probiotics in psoriasis treatment: a systematic review","volume":"12","author":"Buhas","year":"2022","journal-title":"Life"},{"issue":"2","key":"10.1016\/j.micpath.2025.107940_bib76","first-page":"457","article-title":"Synbiotics in atopic dermatitis: clinical trial evidence and perspectives","volume":"76","author":"Noll","year":"2021","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.micpath.2025.107940_bib77","first-page":"414","article-title":"Synbiotics in the prevention and treatment of atopic dermatitis: a meta-analysis of randomized controlled trials","volume":"37","author":"Chang","year":"2016","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.micpath.2025.107940_bib78","article-title":"Bacteriophage therapy as a treatment for skin infections: current perspectives and challenges","volume":"9","author":"Farf\u00e1n","year":"2022","journal-title":"Front. Med."},{"issue":"8","key":"10.1016\/j.micpath.2025.107940_bib79","first-page":"927","article-title":"Bacteriophages as alternative therapy for acne and skin infections","volume":"58","author":"Castillo","year":"2019","journal-title":"Int. J. Dermatol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107940_bib80","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1473-3099(18)30482-1","article-title":"Efficacy and tolerability of a bacteriophage cocktail to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomized, controlled, double-blind phase 1\/2 trial","volume":"19","author":"Jault","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107940_bib81","first-page":"419","article-title":"Development of bacteriophage-loaded hydrogel dressings for burn wound infections","volume":"51","author":"Kaur","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107940_bib82","first-page":"1","article-title":"Bacteriophage therapy for treating musculoskeletal infections: state of the art and challenges ahead","volume":"8","author":"Metsemakers","year":"2023","journal-title":"Journal of Bone and Joint Infection"},{"key":"10.1016\/j.micpath.2025.107940_bib83","first-page":"1","article-title":"Advances in topical drug delivery systems for dermatological disorders","volume":"349","author":"Jain","year":"2022","journal-title":"J. Contr. Release"},{"issue":"3","key":"10.1016\/j.micpath.2025.107940_bib84","first-page":"157","article-title":"Novel topical drug formulations in dermatology: current status and future perspectives","volume":"9","author":"Rabindranathnambi","year":"2021","journal-title":"Pharm. Nanotechnol."},{"key":"10.1016\/j.micpath.2025.107940_bib85","article-title":"Nanocarriers for skin delivery: overcoming the barrier","volume":"185","author":"Pierre","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.micpath.2025.107940_bib86","first-page":"923","article-title":"Nanoparticle-based topical formulations: a promising strategy for dermal and transdermal drug delivery","volume":"13","author":"Paiva-Santos","year":"2021","journal-title":"Pharmaceutics"},{"issue":"19","key":"10.1016\/j.micpath.2025.107940_bib87","first-page":"5852","article-title":"Cannabis sativa and skin health: Antioxidant, anti-inflammatory, and anti-aging properties","volume":"26","author":"Martinelli","year":"2021","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.micpath.2025.107940_bib88","first-page":"1123","article-title":"Plant-derived natural products in dermatology: current applications and future perspectives","volume":"24","author":"Michalak","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.micpath.2025.107940_bib89","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000370220","article-title":"Atopic dermatitis: global epidemiology and risk factors","volume":"66","author":"Nutten","year":"2015","journal-title":"Ann. Nutr. Metab."},{"key":"10.1016\/j.micpath.2025.107940_bib90","first-page":"255","article-title":"The skin and gut microbiome in atopic dermatitis: current perspectives","volume":"14","author":"Khadka","year":"2021","journal-title":"Clin. Cosmet. Invest. Dermatol."},{"issue":"11","key":"10.1016\/j.micpath.2025.107940_bib91","first-page":"1744","article-title":"The skin microbiome and atopic dermatitis: review and perspectives","volume":"72","author":"Hulshof","year":"2017","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.micpath.2025.107940_bib92","first-page":"15","article-title":"The gut-skin axis in atopic dermatitis: insights from microbiome research","volume":"20","author":"Rapin","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.micpath.2025.107940_bib93","doi-asserted-by":"crossref","first-page":"354","DOI":"10.4168\/aair.2018.10.4.354","article-title":"Microbiome in the gut-skin axis in atopic dermatitis","volume":"10","author":"Lee","year":"2018","journal-title":"Allergy, Asthma & Immunology Research"},{"issue":"5","key":"10.1016\/j.micpath.2025.107940_bib94","first-page":"702","article-title":"The gut-skin axis and its role in atopic dermatitis","volume":"39","author":"Darlenski","year":"2021","journal-title":"Clin. Dermatol."},{"issue":"3","key":"10.1016\/j.micpath.2025.107940_bib95","first-page":"1230","article-title":"Gut microbiome and its role in atopic dermatitis: current evidence","volume":"9","author":"Pollak","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"2","key":"10.1016\/j.micpath.2025.107940_bib96","first-page":"567","article-title":"Biologic therapies in atopic dermatitis and their effects on the skin microbiome","volume":"13","author":"Greenzaid","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.micpath.2025.107940_bib97","article-title":"The role of Cutibacterium acnes phylotypes in acne pathogenesis","volume":"12","author":"Lam","year":"2021","journal-title":"Front. Microbiol."},{"issue":"Suppl. 2","key":"10.1016\/j.micpath.2025.107940_bib98","first-page":"5","article-title":"Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates","volume":"34","author":"Dr\u00e9no","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"2","key":"10.1016\/j.micpath.2025.107940_bib99","first-page":"135","article-title":"Novel insights into Cutibacterium acnes ribotypes and their role in acne vulgaris","volume":"33","author":"Ionescu","year":"2024","journal-title":"Exp. Dermatol."},{"issue":"6","key":"10.1016\/j.micpath.2025.107940_bib100","article-title":"Skin microbiome and acne: a systematic review","volume":"32","author":"Chun-xi","year":"2019","journal-title":"Dermatol. Ther."},{"issue":"1","key":"10.1016\/j.micpath.2025.107940_bib101","first-page":"141","article-title":"The role of microbiome dysbiosis in acne severity","volume":"9","author":"Li","year":"2019","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.micpath.2025.107940_bib102","article-title":"Topical treatments and their effects on skin microbiota in acne patients","volume":"36","author":"Wongtada","year":"2023","journal-title":"Dermatol. Ther."},{"issue":"1","key":"10.1016\/j.micpath.2025.107940_bib103","first-page":"13","article-title":"Topical probiotic therapies for acne: mechanistic insights and clinical benefits","volume":"95","author":"Karoglan","year":"2019","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.micpath.2025.107940_bib105","article-title":"Alterations of the skin microbiome in rosacea patients: a metagenomic study","volume":"14","author":"Zhu","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"3","key":"10.1016\/j.micpath.2025.107940_bib106","first-page":"451","article-title":"Skin microbiome dysbiosis in rosacea: evidence from metagenomic sequencing","volume":"143","author":"Long","year":"2023","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.micpath.2025.107940_bib107","first-page":"201","article-title":"Gut-skin axis and microbiome alterations in rosacea: a systematic review","volume":"65","author":"Mao","year":"2023","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"6","key":"10.1016\/j.micpath.2025.107940_bib108","first-page":"441","article-title":"Rosacea and the microbiome: updates on pathophysiology and emerging treatments","volume":"32","author":"Kim","year":"2020","journal-title":"Ann. Dermatol."},{"issue":"6","key":"10.1016\/j.micpath.2025.107940_bib109","first-page":"860","article-title":"The role of gut microbiota and blood microbiota in rosacea pathogenesis","volume":"37","author":"Tutka","year":"2020","journal-title":"Advances in Dermatology and Allergology\/Post\u0229py Dermatologii i Alergologii"},{"issue":"12","key":"10.1016\/j.micpath.2025.107940_bib110","first-page":"1136","article-title":"Skin microbiome shifts in rosacea: clinical correlations and therapeutic implications","volume":"29","author":"Wang","year":"2020","journal-title":"Exp. Dermatol."},{"issue":"6","key":"10.1016\/j.micpath.2025.107940_bib111","first-page":"1670","article-title":"Skin microbiome in rosacea: review and clinical perspectives","volume":"80","author":"Rainer","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"issue":"10","key":"10.1016\/j.micpath.2025.107940_bib112","first-page":"1421","article-title":"The role of Demodex-associated bacteria in rosacea: new insights into pathogenesis","volume":"30","author":"Foley","year":"2021","journal-title":"Exp. Dermatol."},{"issue":"9","key":"10.1016\/j.micpath.2025.107940_bib113","first-page":"2010","article-title":"Demodex and rosacea: the role of Bacillus oleronius and associated microbiota","volume":"34","author":"Forton","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"Pt 11","key":"10.1016\/j.micpath.2025.107940_bib114","first-page":"1500","article-title":"Potential role of Demodex mites and bacteria in the induction of rosacea","volume":"63","author":"Jarmuda","year":"2014","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.micpath.2025.107940_bib115","article-title":"Gut microbiota and rosacea: a systematic review of human studies","volume":"10","author":"Zhu","year":"2023","journal-title":"Front. Nutr."},{"issue":"11","key":"10.1016\/j.micpath.2025.107940_bib116","first-page":"1886","article-title":"Alterations of gut microbiota in rosacea patients: a case-control study","volume":"8","author":"Yun","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.micpath.2025.107940_bib117","article-title":"Probiotics as novel therapeutics for rosacea: evidence from preclinical and clinical studies","volume":"15","author":"Qi","year":"2024","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.micpath.2025.107940_bib118","article-title":"Temporal stability in chronic wound microbiota is associated with poor healing","volume":"3","author":"Loesche","year":"2018","journal-title":"mSphere"},{"key":"10.1016\/j.micpath.2025.107940_bib119","article-title":"Psoriasis and microbiome modulation: emerging evidence and therapeutic perspectives","volume":"11","author":"Radaschin","year":"2024","journal-title":"Front. Med."},{"key":"10.1016\/j.micpath.2025.107940_bib120","article-title":"Reactivation of HSV-1 and microbiome dysbiosis in psoriasis skin","volume":"13","author":"Cai","year":"2022","journal-title":"Front. Microbiol."},{"issue":"11","key":"10.1016\/j.micpath.2025.107940_bib121","first-page":"3002","article-title":"Microbiome alterations and herpesvirus reactivation in inflammatory skin diseases","volume":"142","author":"M\u00f6ckel","year":"2022","journal-title":"J. Invest. Dermatol."},{"issue":"6","key":"10.1016\/j.micpath.2025.107940_bib122","article-title":"HSV-1 reactivation and its link to microbiome imbalance in psoriasis","volume":"33","author":"Vanni","year":"2020","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.micpath.2025.107940_bib123","article-title":"Microbiome interactions with leishmania parasites: implications for cutaneous leishmaniasis","volume":"13","author":"Weber","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"12","key":"10.1016\/j.micpath.2025.107940_bib124","first-page":"566","article-title":"Leishmania-microbiome interactions: modulation of immunity and parasite virulence","volume":"18","author":"Cunningham","year":"2002","journal-title":"Trends Parasitol."},{"issue":"12","key":"10.1016\/j.micpath.2025.107940_bib125","article-title":"Gut-skin axis and psoriasis: emerging role of microbiome modulation","volume":"24","author":"Arya","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2025.107940_bib126","article-title":"Gut microbiota and its role in psoriasis: from mechanisms to therapy","volume":"14","author":"Choy","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107940_bib127","first-page":"45","article-title":"The gut and skin microbiome in psoriasis: implications for pathogenesis and therapy","volume":"19","author":"Zhu","year":"2023","journal-title":"Expet Rev. Clin. Immunol."},{"issue":"7838","key":"10.1016\/j.micpath.2025.107940_bib128","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1038\/d41586-020-03524-6","article-title":"The skin microbiome","volume":"588","author":"Eisenstein","year":"2020","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.micpath.2025.107940_bib129","first-page":"402","article-title":"The human skin microbiome: a source of innovation for dermatological therapies","volume":"51","author":"Boxberger","year":"2021","journal-title":"Med. Maladies Infect."},{"issue":"2","key":"10.1016\/j.micpath.2025.107940_bib130","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.chom.2020.06.017","article-title":"The skin microbiota: balancing risk and reward","volume":"28","author":"Flowers","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.micpath.2025.107940_bib131","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s40257-020-00536-w","article-title":"Skin microbiota and its interplay with wound healing","volume":"21","author":"Tomic-Canic","year":"2020","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.micpath.2025.107940_bib132","article-title":"Skin microbiome: friend or foe? Clinical implications and therapeutic perspectives","volume":"11","author":"Nied\u017awiedzka-Rystwej","year":"2024","journal-title":"Front. Med."},{"key":"10.1016\/j.micpath.2025.107940_bib133","first-page":"5800","article-title":"Universal skin microbiome in human skin","volume":"11","author":"Bay","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2025.107940_bib134","article-title":"Temporal variability of the human skin microbiome","volume":"13","author":"Wei","year":"2022","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.micpath.2025.107940_bib135","first-page":"87","article-title":"Individualized skin microbiota signatures: implications for dermatological disorders","volume":"106","author":"Potbhare","year":"2022","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.micpath.2025.107940_bib136","article-title":"Translating microbiome research into clinical practice: challenges and opportunities","volume":"9","author":"Zhang","year":"2022","journal-title":"Front. Med."},{"issue":"5","key":"10.1016\/j.micpath.2025.107940_bib137","first-page":"369","article-title":"Bridging basic and clinical research in microbiome studies","volume":"29","author":"Turjeman","year":"2021","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.micpath.2025.107940_bib138","first-page":"381","article-title":"Clinical translation of microbiome research: current challenges and future perspectives","volume":"19","author":"Laudes","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.micpath.2025.107940_bib139","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/bs.pbr.2025.01.002","article-title":"Stress and the gut microbiota-brain axis","volume":"291","author":"Hyder","year":"2025","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.micpath.2025.107940_bib140","article-title":"Ethical and regulatory considerations in skin microbiome research and product development","volume":"11","author":"Smythe","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"6","key":"10.1016\/j.micpath.2025.107940_bib141","first-page":"527","article-title":"Skin microbiome products: regulatory perspectives and challenges","volume":"44","author":"Gueniche","year":"2022","journal-title":"Int. J. Cosmet. Sci."},{"key":"10.1016\/j.micpath.2025.107940_bib142","first-page":"150","article-title":"Ethical considerations in skin microbiome research","volume":"11","author":"Santiago-Rodriguez","year":"2023","journal-title":"Microbiome"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025006655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025006655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:23:06Z","timestamp":1758583386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401025006655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":141,"alternative-id":["S0882401025006655"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107940","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microbiome modulation in dermatological disorders: Current insights and therapeutic prospects - A narrative review","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107940","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107940"}}